DERM Stock Summary and Trading Ideas (Journey Medical | NASDAQ:DERM)

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Journey Medical trades on the NASDAQ stock market under the symbol DERM.

As of September 11, 2026, DERM stock price climbed to $7.23 with 167,197 million shares trading.

DERM has a beta of 1.68, meaning it tends to be more sensitive to market movements. DERM has a correlation of 0.11 to the broad based SPY ETF.

DERM has a market cap of $204.06 million. This is considered a Small Cap stock.

Last quarter Journey Medical reported $18 million in Revenue and -$.01 earnings per share. This fell short of revenue expectation by $-598,200 and exceeded earnings estimates by $.01.

In the last 3 years, DERM traded as high as $9.56 and as low as $2.33.

The top ETF exchange traded funds that DERM belongs to (by Net Assets): VTI, VXF, QQQS, DFMC.

DERM has underperformed the market in the last year with a price return of -1.6% while the SPY ETF gained +17.4%. However, in the short term, DERM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +15.3% vs +3.9% return in SPY. But in the last 2 weeks, DERM shares have been beat by the market, returning -3.2% compared to an SPY return of -0.7%.

DERM support price is $6.80 and resistance is $7.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DERM shares will trade within this expected range on the day.